Skip to content

Contract award record

NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

Notice details

Published
Category
goods
Buyer region
North West

Public buyer and contract winner

Public buyer

NHS England
awarded to

Contract winner

Shire Pharmaceuticals Ltd

Award value£72,000,000

  1. Awarded
    Completed
  2. Start
    Completed
  3. End
    Completed

Work description

NHS Framework Agreement for the supply of Icatibant and C1-Esterase products for the treatment of Hereditary Angioedema. The framework will commence on 1st July 2018 for a period of 12 months until 30th June 2019, with options to extend up to a further 36 months.

Related awards

Source: Contracts Finder · Notice 7400eba6-8e62-4241-879e-a0c574ef4408-229021

View source notice